These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 16336296)

  • 1. Hydroxyurea and splenic irradiation-induced tumour lysis syndrome: a case report and review of the literature.
    Chen SW; Hwang WS; Tsao CJ; Liu HS; Huang GC
    J Clin Pharm Ther; 2005 Dec; 30(6):623-5. PubMed ID: 16336296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imatinib-induced tumor lysis syndrome: report of a case and review of the literature.
    Chang H; Shih LY
    Chang Gung Med J; 2008; 31(5):510-4. PubMed ID: 19097599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute tumor lysis syndrome in solid tumors--a case report and review of the literature.
    Baeksgaard L; Sørensen JB
    Cancer Chemother Pharmacol; 2003 Mar; 51(3):187-92. PubMed ID: 12655435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor lysis syndrome (TLS) following fludarabine therapy for chronic lymphocytic leukemia (CLL): case report and review of the literature.
    Hussain K; Mazza JJ; Clouse LH
    Am J Hematol; 2003 Mar; 72(3):212-5. PubMed ID: 12605395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behcet's disease in a patient with chronic myelogenous leukemia under hydroxyurea treatment: a case report and review of the literature.
    Vaiopoulos G; Terpos E; Viniou N; Nodaros K; Rombos J; Loukopoulos D
    Am J Hematol; 2001 Jan; 66(1):57-8. PubMed ID: 11426495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor lysis syndrome after starting treatment with Gleevec in a patient with chronic myelogenous leukemia.
    Al-Kali A; Farooq S; Tfayli A
    J Clin Pharm Ther; 2009 Oct; 34(5):607-10. PubMed ID: 19744017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute tumor lysis syndrome secondary to hydroxycarbamide in chronic myelomonocytic leukemia.
    Otrock ZK; Taher AT; Mahfouz RA; Makarem JA; Shamseddine AI
    Am J Hematol; 2006 Mar; 81(3):220-1. PubMed ID: 16493602
    [No Abstract]   [Full Text] [Related]  

  • 8. Hydroxyurea induced leg ulcers.
    Abhyankar D; Shende C; Saikia T; Advani SH
    J Assoc Physicians India; 2000 Sep; 48(9):926-7. PubMed ID: 11198798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous tumor lysis syndrome in a patient with chronic myeloid leukemia treated successfully with allopurinol.
    Gartenberg A; Winkel M; Leonard N
    Am J Emerg Med; 2024 Apr; 78():242.e1-242.e3. PubMed ID: 38007380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible leg ulcer due to hydroxyurea in a case of chronic myeloid leukemia.
    Tripathi AK; Ahmad R; Sawlani KK
    J Assoc Physicians India; 2003 Oct; 51():1014-5. PubMed ID: 14719596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ulcers on the legs and feet: a seldom recognised side effect of hydroxyurea].
    Janssen JJ; Ossenkoppele GJ
    Ned Tijdschr Geneeskd; 2003 Aug; 147(31):1517-20. PubMed ID: 12924084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splenic irradiation in myelofibrosis with myeloid metaplasia: a review.
    Elliott MA; Tefferi A
    Blood Rev; 1999 Sep; 13(3):163-70. PubMed ID: 10527268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review.
    Coiffier B; Altman A; Pui CH; Younes A; Cairo MS
    J Clin Oncol; 2008 Jun; 26(16):2767-78. PubMed ID: 18509186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute tumor lysis syndrome secondary to hydroxyurea in acute myeloid leukemia.
    Seki JT; Al-Omar HM; Amato D; Sutton DM
    Ann Pharmacother; 2003 May; 37(5):675-8. PubMed ID: 12708945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour lysis syndrome: new therapeutic strategies and classification.
    Cairo MS; Bishop M
    Br J Haematol; 2004 Oct; 127(1):3-11. PubMed ID: 15384972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splenic irradiation in the treatment of patients with chronic myelogenous leukemia or myelofibrosis with myeloid metaplasia. Results of daily and intermittent fractionation with and without concomitant hydroxyurea.
    Wagner H; McKeough PG; Desforges J; Madoc-Jones H
    Cancer; 1986 Sep; 58(6):1204-7. PubMed ID: 2427184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carfilzomib-associated tumor lysis syndrome.
    Shely RN; Ratliff PD
    Pharmacotherapy; 2014 May; 34(5):e34-7. PubMed ID: 24390940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombotic microangiopathy associated with alpha-interferon therapy for chronic myeloid leukaemia.
    Galesic K; Bozic B; Racic I; Scukanec-Spoljar M
    Nephrology (Carlton); 2006 Feb; 11(1):49-52. PubMed ID: 16509932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergency care: the tumor lysis syndrome.
    Turtureanu-Hanganu E
    Rev Med Chir Soc Med Nat Iasi; 2002; 106(4):705-11. PubMed ID: 14974215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perimalleolar ulcers in hydroxyurea treated patients with concomitant chronic venous disease: diagnostic pitfalls.
    Jain V; Gupta K; Nagpal N
    J Coll Physicians Surg Pak; 2005 Oct; 15(10):658-60. PubMed ID: 19810313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.